Ratio Examination: Beyond Air Inc (XAIR)’s Price-to-Cash and Price-to-Free Cash Flow

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

In the latest session, Beyond Air Inc (NASDAQ: XAIR) closed at $1.12 down -2.61% from its previous closing price of $1.15. In other words, the price has decreased by -$2.61 from its previous closing price. On the day, 0.53 million shares were traded. XAIR stock price reached its highest trading level at $1.22 during the session, while it also had its lowest trading level at $1.11.

Ratios:

For a deeper understanding of Beyond Air Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 3.26 and its Current Ratio is at 3.39. In the meantime, Its Debt-to-Equity ratio is 0.81 whereas as Long-Term Debt/Eq ratio is at 0.79.

Upgrades & Downgrades

In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on July 28, 2023, initiated with a Overweight rating and assigned the stock a target price of $10.

On June 15, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $15.

On April 28, 2021, Truist started tracking the stock assigning a Buy rating and target price of $12.Truist initiated its Buy rating on April 28, 2021, with a $12 target price.

Insider Transactions:

Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 28 ’23 when Avniel Amir sold 13,733 shares for $2.05 per share. The transaction valued at 28,217 led to the insider holds 0 shares of the business.

Avniel Amir sold 11,267 shares of XAIR for $23,234 on Dec 28 ’23. The Chief Business Officer now owns 685,760 shares after completing the transaction at $2.06 per share. On Dec 27 ’23, another insider, Myers Jeff Lynn, who serves as the Chief Medical Officer of the company, sold 3,423 shares for $2.21 each. As a result, the insider received 7,579 and left with 46,577 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, XAIR now has a Market Capitalization of 51408896 and an Enterprise Value of 28687742. For the stock, the TTM Price-to-Sale (P/S) ratio is 74.50 while its Price-to-Book (P/B) ratio in mrq is 1.91. Its current Enterprise Value per Revenue stands at 41.637 whereas that against EBITDA is -0.457.

Stock Price History:

Over the past 52 weeks, XAIR has reached a high of $6.36, while it has fallen to a 52-week low of $1.06. The 50-Day Moving Average of the stock is -24.26%, while the 200-Day Moving Average is calculated to be -45.03%.

Shares Statistics:

For the past three months, XAIR has traded an average of 303.83K shares per day and 451370 over the past ten days. A total of 45.90M shares are outstanding, with a floating share count of 35.39M. Insiders hold about 22.91% of the company’s shares, while institutions hold 22.60% stake in the company. Shares short for XAIR as of 1714435200 were 4038733 with a Short Ratio of 13.29, compared to 1711584000 on 3496144. Therefore, it implies a Short% of Shares Outstanding of 4038733 and a Short% of Float of 9.7799994.

Most Popular

[the_ad id="945"]